MPS Pharmaa Ltd: Intrinsic Value & Share Price Analysis

Q: What is the intrinsic value of MPS Pharmaa Ltd and is it undervalued?

As of 20 April 2026, MPS Pharmaa Ltd's intrinsic value is 1.52, which is 7.88% lower than the current market price of 1.65, suggesting the stock is overvalued. Calculated using the PE ratio method factoring in ROE (59.0 %), book value (0.33), dividend yield (0.00 %), and 5-year EPS CAGR.

Q: What is the current share price and 52-week range of MPS Pharmaa Ltd?

MPS Pharmaa Ltd is trading at 1.65 as of 20 April 2026, with a FY2026-2027 high of 3.17 and low of 1.57. The stock is currently near its 52-week low. Market cap stands at 3.15 Cr..

Q: Is MPS Pharmaa Ltd financially healthy?

Key indicators: ROCE of 9.79 % is on the lower side. Dividend yield is 0.00 %.

Q: Is MPS Pharmaa Ltd profitable and how is the profit trend?

MPS Pharmaa Ltd reported a net profit of -1 Cr in Mar 2025. Compared to 0 Cr in Mar 2022, the net profit shows a mixed trend.

Fair Value

₹2.38Undervalued by 44.24%vs CMP ₹1.65

P/E (15.0) × ROE (59.0%) × BV (₹0.33) × DY (2.00%)

Defaults: P/E=15

₹1.52Fairly Valued by 7.88%vs CMP ₹1.65

MoS: -8.6% (Negative)Confidence: 28/100 (Low)Models: 1 Under, 1 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹2.22	63%	Under (+34.5%)
Net Asset Value	Assets	₹0.34	38%	Over (-79.4%)
Consensus (2 models)		₹1.52	100%	Fairly Valued

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -7.0% · Defaults: P/E=15

*Investments are subject to market risks

Analyst Summary

MPS Pharmaa Ltd operates in the Pharmaceuticals segment, NSE: ADVIKLA | BSE: 531686, current market price is ₹1.65, market cap is 3.15 Cr.. At a glance, ROE is 59.0 %, ROCE is 9.79 %, book value is 0.33, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹1.52, around 7.9% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹0 Cr, while latest net profit is about ₹-1 Cr with a prior-period change of -8.4%. This analysis page also carries profit and loss, shareholding pattern, ratio panels data, which improves the depth of the template beyond a thin price-only snapshot. The 52-week range shown on this page is 3.17/1.57, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisMPS Pharma Ltd. is a Public Limited Listed company incorporated on 09/09/1994 and has its registered office in the State of Haryana, India. Company's Corporate Identification Number(CIN) is L74899HR1994PLC038300 and registration number is 038300. Currently company belongs to the…

This summary is generated from the stock page data available for MPS Pharmaa Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

MPS Pharmaa Ltd scores 49/100 (Average)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health39/100 · Weak

ROCE 9.8% AverageROE 59.0% ExcellentD/E 0.48 ModerateInterest Coverage 0.0x RiskyProfitable 0/5 years Inconsistent

Smart Money50/100 · Moderate

Promoter holding at 35.9% Stable

Earnings Quality65/100 · Strong

OPM expanding (-1,133% → 0%) Improving

Quarterly Momentum50/100 · Moderate

Industry Rank40/100 · Moderate

ROCE 9.8% vs industry 16.4% Below peersROE 59.0% vs industry 15.2% Above peers3Y sales CAGR: -100% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: March 24, 2026, 5:17 am

Market Cap	3.15 Cr.
Current Price	1.65
Intrinsic Value	₹1.52
High / Low	3.17/1.57
Stock P/E
Book Value	0.33
Dividend Yield	0.00 %
ROCE	9.79 %
ROE	59.0 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for MPS Pharmaa Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Lactose (India) Ltd	106 Cr.	84.2	137/76.0	21.9	49.6	0.00 %	12.9 %	9.69 %	10.0
MPS Pharmaa Ltd	3.15 Cr.	1.65	3.17/1.57		0.33	0.00 %	9.79 %	59.0 %	10.0
Gujarat Themis Biosyn Ltd	2,692 Cr.	247	479/222	56.3	24.3	0.27 %	27.3 %	21.7 %	1.00
Gujarat Terce Laboratories Ltd	25.3 Cr.	32.5	68.4/29.0		10.1	0.00 %	41.4 %	14.6 %	10.0
Gujarat Inject (Kerala) Ltd	120 Cr.	82.1	82.1/17.0	481	6.93	0.00 %	13.5 %	11.0 %	10.0
Industry Average	19,815.15 Cr	1,053.84		53.84	201.20	0.39%	16.35%	15.16%	6.10

All Competitor Stocks of MPS Pharmaa Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Expenses	0.23	0.31	0.19	0.21	0.18	0.21	0.19	0.19	0.18	0.19	0.19	0.19	0.19
Operating Profit	-0.23	-0.31	-0.19	-0.21	-0.18	-0.21	-0.19	-0.19	-0.18	-0.19	-0.19	-0.19	-0.19
OPM %
Other Income	0.00	0.02	0.03	0.06	0.00	0.00	0.00	0.00	0.04	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04
Profit before tax	-0.27	-0.33	-0.20	-0.19	-0.22	-0.25	-0.23	-0.23	-0.18	-0.23	-0.23	-0.23	-0.23
Tax %	0.00%	-3.03%	-5.00%	-5.26%	-4.55%	0.00%	-4.35%	-4.35%	0.00%	21.74%	-4.35%	-4.35%	-4.35%
Net Profit	-0.26	-0.32	-0.19	-0.18	-0.21	-0.24	-0.22	-0.22	-0.17	-0.28	-0.22	-0.22	-0.22
EPS in Rs	-0.14	-0.17	-0.10	-0.09	-0.11	-0.13	-0.12	-0.12	-0.09	-0.15	-0.12	-0.12	-0.12

Last Updated: March 3, 2026, 8:16 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 16, 2026, 5:14 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	30.27	12.24	1.35	2.84	4.09	0.83	0.00	0.00	0.03	0.00	0.00	0.00	0.00
Expenses	27.43	11.43	1.84	9.72	4.62	1.56	0.67	4.14	0.71	0.95	0.80	0.77	0.76
Operating Profit	2.84	0.81	-0.49	-6.88	-0.53	-0.73	-0.67	-4.14	-0.68	-0.95	-0.80	-0.77	-0.76
OPM %	9.38%	6.62%	-36.30%	-242.25%	-12.96%	-87.95%			-2,266.67%
Other Income	0.01	0.00	0.00	0.03	0.06	0.02	0.01	0.20	0.26	0.02	0.09	0.05	0.00
Interest	1.20	1.08	0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.68	0.65	0.62	0.59	0.59	0.59	0.57	0.56	0.51	0.15	0.15	0.15	0.16
Profit before tax	0.97	-0.92	-1.19	-7.44	-1.06	-1.30	-1.23	-4.50	-0.93	-1.08	-0.86	-0.87	-0.92
Tax %	50.52%	-26.09%	-0.84%	-0.81%	-17.92%	-3.85%	-5.69%	-1.78%	-84.95%	-1.85%	-2.33%	3.45%
Net Profit	0.46	-0.68	-1.19	-7.39	-0.87	-1.25	-1.17	-4.42	-0.14	-1.05	-0.83	-0.90	-0.94
EPS in Rs	0.31	-0.45	-0.62	-3.87	-0.46	-0.65	-0.61	-2.31	-0.07	-0.55	-0.43	-0.47	-0.51
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	-247.83%	-75.00%	-521.01%	88.23%	-43.68%	6.40%	-277.78%	96.83%	-650.00%	20.95%	-8.43%
Change in YoY Net Profit Growth (%)	0.00%	172.83%	-446.01%	609.24%	-131.91%	50.08%	-284.18%	374.61%	-746.83%	670.95%	-29.39%

MPS Pharmaa Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Compounded Profit Growth
10 Years:	-4%
5 Years:	4%
3 Years:	%
TTM:	-5%

Stock Price CAGR
10 Years:	-12%
5 Years:	%
3 Years:	5%
1 Year:	-47%

Return on Equity
10 Years:	-24%
5 Years:	-44%
3 Years:	-39%
Last Year:	-59%

Last Updated: September 5, 2025, 3:51 pm

Balance Sheet

Last Updated: December 4, 2025, 3:07 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	15.03	15.03	19.11	19.11	19.11	19.11	19.11	19.11	19.11	19.11	19.11	19.11	19.11
Reserves	5.05	4.17	-0.13	-7.50	-8.35	-9.58	-10.75	-15.16	-15.29	-16.32	-17.14	-18.03	-18.47
Borrowings	8.22	7.78	6.65	2.90	2.90	2.51	2.53	5.68	5.81	6.77	7.27	7.46	7.51
Other Liabilities	6.52	5.38	2.94	6.41	5.49	5.52	5.52	1.67	0.53	0.63	0.70	0.80	0.84
Total Liabilities	34.82	32.36	28.57	20.92	19.15	17.56	16.41	11.30	10.16	10.19	9.94	9.34	8.99
Fixed Assets	15.18	8.21	7.64	7.06	6.47	5.88	5.26	4.68	4.17	4.14	4.01	3.83	3.74
CWIP	0.00	6.15	6.15	5.51	5.21	5.43	5.02	3.90	3.42	3.40	3.26	2.91	2.65
Investments	0.92	0.92	0.92	0.92	0.92	0.92	0.92	0.54	0.54	0.54	0.54	0.54	0.54
Other Assets	18.72	17.08	13.86	7.43	6.55	5.33	5.21	2.18	2.03	2.11	2.13	2.06	2.06
Total Assets	34.82	32.36	28.57	20.92	19.15	17.56	16.41	11.30	10.16	10.19	9.94	9.34	8.99

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	4.62	2.16	1.25	0.37	-0.34	0.61	-0.49	-0.93	-4.34	-0.87	-0.63	-0.57
Cash from Investing Activity +	-6.39	-0.44	-0.05	0.63	0.30	-0.22	0.46	1.54	0.46	-0.10	0.12	0.38
Cash from Financing Activity +	1.72	-1.75	-1.19	-0.98	0.00	-0.39	0.03	-0.61	3.88	0.96	0.51	0.18
Net Cash Flow	-0.05	-0.03	0.01	0.02	-0.04	0.00	0.00	0.00	0.00	-0.01	0.00	0.00
Free Cash Flow	-1.77	1.72	1.20	1.00	-0.04	0.39	-0.04	0.22	-3.88	-0.97	-0.51	-0.19
CFO/OP	169%	267%	-292%	-5%	64%	-84%	73%	22%	638%	92%	79%	74%

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-5.38	-6.97	-7.14	-9.78	-3.43	-3.24	-3.20	-9.82	-6.49	-7.72	-8.07	-8.23

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	104.30	229.02	1,154.48	532.08	344.47	1,147.77			365.00
Inventory Days	94.81	274.40	6,543.93	50.05	58.94	253.72			4,015.00	4,562.50
Days Payable	62.46	123.03	556.19	15.95	14.48	71.22			876.00	1,825.00
Cash Conversion Cycle	136.65	380.39	7,142.22	566.19	388.94	1,330.27			3,504.00
Working Capital Days	99.72	208.74	1,724.96	-115.67	-87.46	-848.73			-49,396.67
ROCE %	8.18%	0.58%	-4.22%	-37.07%	-7.53%	-10.12%	-10.73%	-45.61%	-9.66%	-11.26%	-9.15%	-9.79%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	35.89%	35.89%	35.89%	35.89%	35.89%	35.89%	35.89%	35.89%	35.89%	35.89%	35.89%	35.89%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.58%	0.58%	0.58%	0.58%	0.58%
Public	64.11%	64.11%	64.11%	64.11%	64.11%	64.12%	64.11%	63.52%	63.51%	63.53%	63.52%	63.53%
No. of Shareholders	4,494	4,475	4,454	4,435	4,414	4,398	4,386	4,397	4,422	4,445	4,433	4,425

Shareholding Pattern Chart

No. of Shareholders

MPS Pharmaa Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	-0.47	-0.43	-0.55	-0.07	-2.31
Diluted EPS (Rs.)	-0.47	-0.43	-0.55	-0.07	-2.31
Cash EPS (Rs.)	-0.39	-0.35	-0.47	0.19	-2.02
Book Value[Excl.RevalReserv]/Share (Rs.)	0.56	1.03	1.46	2.00	2.07
Book Value[Incl.RevalReserv]/Share (Rs.)	0.56	1.03	1.46	2.00	2.07
Revenue From Operations / Share (Rs.)	0.00	0.00	0.00	0.01	0.00
PBDIT / Share (Rs.)	-0.37	-0.36	-0.48	-0.21	-2.06
PBIT / Share (Rs.)	-0.45	-0.44	-0.56	-0.48	-2.35
PBT / Share (Rs.)	-0.45	-0.44	-0.56	-0.48	-2.35
Net Profit / Share (Rs.)	-0.46	-0.43	-0.54	-0.07	-2.31
PBDIT Margin (%)	0.00	0.00	0.00	-1290.32	0.00
PBIT Margin (%)	0.00	0.00	0.00	-2876.76	0.00
PBT Margin (%)	0.00	0.00	0.00	-2880.22	0.00
Net Profit Margin (%)	0.00	0.00	0.00	-437.31	0.00
Return on Networth / Equity (%)	-83.08	-42.21	-37.63	-3.70	-111.78
Return on Capital Employeed (%)	-68.24	-38.85	-35.47	-22.83	-96.84
Return On Assets (%)	-9.62	-8.36	-10.31	-1.39	-39.07
Total Debt / Equity (X)	6.90	3.69	2.42	1.52	0.48
Current Ratio (X)	0.25	0.27	0.29	0.33	0.32
Quick Ratio (X)	0.19	0.20	0.22	0.24	0.24
Inventory Turnover Ratio (X)	0.00	0.00	0.08	0.03	0.00
Interest Coverage Ratio (X)	-1438.08	-563.32	-1722.46	-373.22	-7579.04
Interest Coverage Ratio (Post Tax) (X)	-1800.93	-662.72	-1955.76	-125.49	-8500.46
Enterprise Value (Cr.)	13.53	13.40	10.77	8.45	3.35
EV / Net Operating Revenue (X)	0.00	0.00	0.00	261.01	0.00
EV / EBITDA (X)	-18.88	-19.00	-11.65	-20.23	-0.85
MarketCap / Net Operating Revenue (X)	0.00	0.00	0.00	82.05	0.00
Price / BV (X)	5.63	3.12	1.44	0.69	0.36
Price / Net Operating Revenue (X)	0.00	0.00	0.00	86.88	0.00
EarningsYield	-0.14	-0.13	-0.26	-0.05	-3.08

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

MPS Pharma Ltd. is a Public Limited Listed company incorporated on 09/09/1994 and has its registered office in the State of Haryana, India. Company's Corporate Identification Number(CIN) is L74899HR1994PLC038300 and registration number is 038300. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 19.11 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	138, Roz-Ka-Meo Industrial Area, Sohna, Mewat Dist. Haryana 122103	Contact not found

Management
Name	Position Held
Mr. Peeyush Kumar Aggarwal	Managing Director
Mr. Ram Niwas Sharma	Non Independent Director
Ms. Madhu Sharma	Independent Director
Mr. Ajay Sharma	Independent Director

FAQ

What is the intrinsic value of MPS Pharmaa Ltd and is it undervalued?

As of 20 April 2026, MPS Pharmaa Ltd's intrinsic value is ₹1.52, which is 7.88% lower than the current market price of ₹1.65, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (59.0 %), book value (₹0.33), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of MPS Pharmaa Ltd?

MPS Pharmaa Ltd is trading at ₹1.65 as of 20 April 2026, with a FY2026-2027 high of ₹3.17 and low of ₹1.57. The stock is currently near its 52-week low. Market cap stands at ₹3.15 Cr..

How does MPS Pharmaa Ltd's P/E ratio compare to its industry?

MPS Pharmaa Ltd has a P/E ratio of , which is below the industry average of 53.84. This is broadly in line with or below the industry average.

Is MPS Pharmaa Ltd financially healthy?

Key indicators for MPS Pharmaa Ltd: ROCE of 9.79 % is on the lower side compared to the industry average of 16.35%; ROE of 59.0 % shows strong shareholder returns. Dividend yield is 0.00 %.

Is MPS Pharmaa Ltd profitable and how is the profit trend?

MPS Pharmaa Ltd reported a net profit of ₹-1 Cr in Mar 2025. Compared to ₹0 Cr in Mar 2022, the net profit shows a mixed trend.

Does MPS Pharmaa Ltd pay dividends?

MPS Pharmaa Ltd has a dividend yield of 0.00 % at the current price of ₹1.65. The company is currently not paying meaningful dividends.